Monday, October 30, 2017

Threatened By Amazon? CVS Health Makes A $66 Billion Bid For Aetna | CNBC


NYT Columnist Reveals The Six Cities That Are Frontrunners For Amazon’s ...


Monday, October 16, 2017

ESOcast 133: ESO Telescopes Observe First Light from Gravitational Wave ...


Federal Judge Nixes Allergan Patents - blockbuster drug may be copied now

A US district judge for Eastern Texas,William Bryson,has tossed out Allergan's patents on its blockbuster dry eye treatment Restasis,which has been marketed by a long-running TV commercial campaign.The judge said the patents were based on obvious ideas.He additionally disliked Allergan's attempt to shield the patents by transferring the rights to the St.Regis Mohawk Indian tribe in New York State last month-a move Members of Congress have also criticised.Allergan's rivals have been seeking the ruling,led by Mylan NV and Teva Pharmaceutical Industries.*
The ruling may clear the way for other drugmakers to produce generic versions of Restasis.*
Last year,Restasis generated 10% of Allergan's revenue and 15% of its profits.The company,through its chief legal officer,Robert Bailey,said it was disappointed in the decision and was considering all of its options.*
As of time of publication,Allergan was down 3.51%;Teva had dropped 1.84%;while Mylan rose 0.59%.*
Allergan plc (AGN),Mylan NV (MYL),Teva Pharmaceutical Industries Ltd ADR (TEVA)

Sunday, October 8, 2017

Boeing to Acquire Aurora Flight Sciences - Avionics - photo

Boeing to Acquire Aurora Flight Sciences - Avionics: Boeing plans to acquire Aurora Flight Sciences Corp., the to-be subsidiary said. Although the sale is not yet official, the two parties have signed an agreement. Terms have not been disclosed. “The combined strength and innovation of our teams will advance the development of autonomy for our commercial and military systems,” said Greg Hyslop, CTO …

Monday, October 2, 2017

Goldman Sachs and Fidelity Attracted by Digital Currencies

At least two major financial firms,Goldman Sachs and Fidelity,are actively searching out the realm of Bitcoin and Ethereum as investor demand for exposure to digital currencies swells.A Goldman spokeswoman told The Wall Street Journal that:
In response to client interest in digital currencies,we are exploring how best to serve them in this space.*
Indeed,Goldman has been following the currencies for some time now.One of its vice presidents issued a report on Bitcoin price action earlier this year,when it sharply increased to more than 5,000 dollars.The price has since declined all the way to below 1,000,before recovering  to over 4,000.*
About 75 funds related to digital currencies have sprung up so far.*
Privately held Fidelity Investments,Inc. have also been probing this prospect,with CEO Abigail Johnson revealing they have made several venture investments in Bitcoin-related businesses and are looking at the blockchain technologies that underlie the currencies with a number of top universities.
Fidelity has gone even farther than Goldman,setting up a digital currency mining operation for educational purposes that uses hardware from 21 Inc.Ms.Johnson said:
We set up a small Bitcoin and Ethereum mining operation...that miraculously now is making a lot of money.*
The Ark Innovation exchange-traded fund provides exposure to digital currencies and other advanced concepts.*
Among the skeptics,JP Morgan Chase CEO Jamie Dimon has dismissed digital currencies as being a fraud.*
At time of publication,the currency prices were:
Bitcoin (BTC) 4360.00 +1.20%
Ethereum (ETH) 294.97 -2.13%
Bitcoin Futures 4318.00 + 1.38%*
Goldman Sachs (GS),Ark Innovation ETF (ARKK)